The Third Group of the B7-Cd28 Immune Checkpoint Family: HHLA2, TMIGD2, B7x, and B7-H3

Immunological Reviews - United Kingdom
doi 10.1111/imr.12521
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2

Clinical Cancer Research
Cancer ResearchOncology
2015English

B7-H3 in Cancer – Beyond Immune Regulation

Trends in Cancer
Cancer ResearchOncology
2018English

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated With EGFR Mutational Status

Clinical Cancer Research
Cancer ResearchOncology
2016English

The Contrasting Role of B7-H3

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Cross-Linking the B7 Family Molecule B7-Dc Directly Activates Immune Functions of Dendritic Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
2010English

The Immunomodulatory Proteins B7-Dc, B7-H2, and B7-H3 Are Differentially Expressed Across Gestation in the Human Placenta

American Journal of Pathology
Forensic MedicinePathology
2005English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Microglial Expression of the B7 Family Member B7 Homolog 1 Confers Strong Immune Inhibition: Implications for Immune Responses and Autoimmunity in the CNS

Journal of Neuroscience
Neuroscience
2005English

A B7-Cd28 Family Based Signature Demonstrates Significantly Different Prognoses and Tumor Immune Landscapes in Lung Adenocarcinoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy